Literature DB >> 21742771

Comparing signaling networks between normal and transformed hepatocytes using discrete logical models.

Julio Saez-Rodriguez1, Leonidas G Alexopoulos, Mingsheng Zhang, Melody K Morris, Douglas A Lauffenburger, Peter K Sorger.   

Abstract

Substantial effort in recent years has been devoted to constructing and analyzing large-scale gene and protein networks on the basis of "omic" data and literature mining. These interaction graphs provide valuable insight into the topologies of complex biological networks but are rarely context specific and cannot be used to predict the responses of cell signaling proteins to specific ligands or drugs. Conversely, traditional approaches to analyzing cell signaling are narrow in scope and cannot easily make use of network-level data. Here, we combine network analysis and functional experimentation by using a hybrid approach in which graphs are converted into simple mathematical models that can be trained against biochemical data. Specifically, we created Boolean logic models of immediate-early signaling in liver cells by training a literature-based prior knowledge network against biochemical data obtained from primary human hepatocytes and 4 hepatocellular carcinoma cell lines exposed to combinations of cytokines and small-molecule kinase inhibitors. Distinct families of models were recovered for each cell type, and these families clustered topologically into normal and diseased sets.

Entities:  

Mesh:

Year:  2011        PMID: 21742771      PMCID: PMC3207250          DOI: 10.1158/0008-5472.CAN-10-4453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Insulin signaling through insulin receptor substrate 1 and 2 in normal liver development.

Authors:  Leila Khamzina; Philip A Gruppuso; Jack R Wands
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

Review 2.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

3.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

4.  A compendium of signals and responses triggered by prodeath and prosurvival cytokines.

Authors:  Suzanne Gaudet; Kevin A Janes; John G Albeck; Emily A Pace; Douglas A Lauffenburger; Peter K Sorger
Journal:  Mol Cell Proteomics       Date:  2005-07-18       Impact factor: 5.911

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 6.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

7.  Bayesian network approach to cell signaling pathway modeling.

Authors:  Karen Sachs; David Gifford; Tommi Jaakkola; Peter Sorger; Douglas A Lauffenburger
Journal:  Sci STKE       Date:  2002-09-03

8.  Prediction of a gene regulatory network linked to prostate cancer from gene expression, microRNA and clinical data.

Authors:  Eric Bonnet; Tom Michoel; Yves Van de Peer
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

9.  Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation.

Authors:  Patricia L Podolin; James F Callahan; Brian J Bolognese; Yue H Li; Karey Carlson; T Gregg Davis; Geoff W Mellor; Christopher Evans; Amy K Roshak
Journal:  J Pharmacol Exp Ther       Date:  2004-08-17       Impact factor: 4.030

10.  Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.

Authors:  M J Saad; E Araki; M Miralpeix; P L Rothenberg; M F White; C R Kahn
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more
  59 in total

Review 1.  Models of signalling networks - what cell biologists can gain from them and give to them.

Authors:  Kevin A Janes; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2013-05-01       Impact factor: 5.285

Review 2.  Boolean network modeling in systems pharmacology.

Authors:  Peter Bloomingdale; Van Anh Nguyen; Jin Niu; Donald E Mager
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-01-06       Impact factor: 2.745

3.  Implementation of systems theory in liver cancer research.

Authors:  Federico Pinna; Kai Breuhahn
Journal:  Hepat Oncol       Date:  2015-01-12

Review 4.  The recurrent architecture of tumour initiation, progression and drug sensitivity.

Authors:  Andrea Califano; Mariano J Alvarez
Journal:  Nat Rev Cancer       Date:  2016-12-15       Impact factor: 60.716

5.  MONOMIALS AND BASIN CYLINDERS FOR NETWORK DYNAMICS.

Authors:  Daniel Austin; Ian H Dinwoodie
Journal:  SIAM J Appl Dyn Syst       Date:  2015       Impact factor: 2.316

6.  On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology.

Authors:  Rohit T Rao; Megerle L Scherholz; Clara Hartmanshenn; Seul-A Bae; Ioannis P Androulakis
Journal:  Comput Chem Eng       Date:  2017-06-03       Impact factor: 3.845

7.  Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.

Authors:  Anil Korkut; Weiqing Wang; Emek Demir; Bülent Arman Aksoy; Xiaohong Jing; Evan J Molinelli; Özgün Babur; Debra L Bemis; Selcuk Onur Sumer; David B Solit; Christine A Pratilas; Chris Sander
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

8.  STL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classification.

Authors:  Szymon Stoma; Alexandre Donzé; François Bertaux; Oded Maler; Gregory Batt
Journal:  PLoS Comput Biol       Date:  2013-05-09       Impact factor: 4.475

9.  Reconstructing Boolean models of signaling.

Authors:  Roded Sharan; Richard M Karp
Journal:  J Comput Biol       Date:  2013-01-03       Impact factor: 1.479

10.  Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.

Authors:  Marcela Cataldi; Nirav R Shah; Sébastien A Felt; Valery Z Grdzelishvili
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.